Skip to content

Clinical study for sufentanil combined with nalbuphine for epidural labor analgesia

Clinical study for sufentanil combined with nalbuphine for epidural labor analgesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029698
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain

Interventions

Group SN:sufentanil combined with nalbuphine

Sponsors

Qingdao Women and Children's Hospital affiliated to Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. The American anesthesiologists Association (ASA) physical status I and II; 2. Aged 20-40 years; 3. Height is 150 to 175 cm; 4. BMI 18.5-35kg/m2; 5. Single station, head presentation; 6. The indexes of heart, liver, kidney and blood were all in normal range; 7. Obtain informed consent and volunteer to join according to GCP regulations.

Exclusion criteria

Exclusion criteria: 1. Important organs include primary diseases, such as hyperthyroidism, cardiopulmonary diseases, neuromuscular diseases, etc.; 2. Mentally or physically handicapped patients; 3. A history of alcohol or drug abuse is suspected or true; 4. Allergic constitutions such as allergies to two or more drugs or foods, or known allergies to nalbuphine and sufentanil; 5. Epidural anesthesia is contraindicated.

Design outcomes

Primary

MeasureTime frame
Onset time of analgesia;the time elapsed to the patient's first request for further analgesia;Neonatal neuroadaptability score;Ropivacaine consumption;

Secondary

MeasureTime frame
Modified Bromage grading method;pruritus;nausea;vomiting;

Countries

China

Contacts

Public ContactChen Zuolei

Anesthesia department of women and children's Hospital, Qingdao Women and Children's Hospital affiliated to Qingdao University

chenzuolei_qd@163.com+86 18561967939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026